entity

gut

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about gut: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections
21Hypotheses
14Analyses
3Outgoing
2Incoming
9Experiments
20Debates

No AI portrait yet

Wiki Pages (3)

Knowledge base pages for this entity

gut-brain-axis-tauopathy

mechanism · 3109 words

environmental-toxin-mitochondrial-gut-axis-parkinsons

general · 1034 words

gut-immune-brain-axis-parkinsons

general · 665 words

Outgoing (3)

TargetRelationTypeStr
Fat Absorptioninvolved_inprocess0.90
central nervous systeminteracts_withbrain_region0.90
OBESITYassociated_withdisease0.80

Incoming (2)

SourceRelationTypeStr
Brainmediatescell_type0.90
Brain-to-Gut Signalmediatesmechanism0.85

Targeting Hypotheses (21)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming 0.907 neurodegeneration What are the mechanisms by which gut mic
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam 0.789 neurodegeneration What are the mechanisms by which gut mic
Gut-BBB Axis: Tributyrin/Butyrate HDAC Inhibition Epigenetic 0.712 - Blood-brain barrier permeability changes
TLR4/MyD88/NF-κB Axis Blockade to Interrupt LPS-Mediated Gut 0.703 neurodegeneration How do gut microbiome-derived metabolite
Leaky Gut LPS Translocation Activates Systemic TLR4/MyD88 Si 0.670 neurodegeneration How does gut microbiome dysbiosis contri
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A 0.669 neurodegeneration What are the mechanisms by which gut mic
Physiological SCFAs may reduce alpha-synuclein burden primar 0.650 neurodegeneration Do physiological concentrations of SCFAs
Gut-Brain Axis M-Cell Modulation 0.629 - Neuroinflammation and microglial priming
H7: Enteric Nervous System Alpha-Synuclein Propagation Block 0.620 neurodegeneration How does engineered C. butyricum cross t
Correcting Gut Microbial Dopamine Imbalance to Support Syste 0.606 neurodegeneration What are the mechanisms by which gut mic
Gut Bacterial Metabolite-AhR Dysregulation Converts SCFA-Def 0.580 neurodegeneration How does gut microbiome dysbiosis contri
Gut-Brain Axis Microbiome Modulation 0.557 Alzheimer's disease Neuroinflammation and microglial priming
TLR2 Recognition of Gut-Derived Fungal and Bacterial D-Alany 0.550 neurodegeneration How does gut microbiome dysbiosis contri
Cross-Seeding: Gut Microbiome-Derived Bacterial Curli and Fu 0.540 neurodegeneration How does gut microbiome dysbiosis contri
Gut Barrier Permeability-α-Synuclein Axis Modulation 0.533 neurodegeneration What are the mechanisms by which gut mic
Gut-derived butyrate reprograms microglia for amyloid cleara 0.525 Alzheimer's disease Gut-Brain Axis Therapeutics for AD
Gut dysbiosis-driven monocyte reprogramming toward NETotic p 0.380 Alzheimer's disease Systemic immune profiling and peripheral
Gut butyrate deficiency impairs microglial amyloid clearance 0.380 Alzheimer's disease Gut-Brain Axis Therapeutics for Alzheime
plasma LPS-binding protein separates causal from compensator 0.346 neurodegeneration How does gut microbiome dysbiosis contri
TLR4 priming is the actionable driver in: How does gut micro 0.343 neurodegeneration How does gut microbiome dysbiosis contri
microglial inflammasome tone defines the therapeutic window 0.341 neurodegeneration How does gut microbiome dysbiosis contri

Mentioning Analyses (14)

Scientific analyses that reference this entity

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegen

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.728

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegen

neurodegeneration | 2026-04-26 | 3 hypotheses Top: 0.346

Gut-Brain Axis in Parkinson's Disease: Molecular Mechanisms, Neuroinflammation,

neurodegeneration | 2026-04-26 | 4 hypotheses Top: 0.630

Gut Microbiome Analysis in Parkinson's Disease

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.778

How do gut microbiome-derived metabolites SCFAs LPS TMAO influence alpha-synucle

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.703

Experiments (9)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Electroacupuncture ST37 treatment for DSS-induced colitis in mice validation colitis 0.950 0.00 mice proposed N/A
Resveratrol protection against renal I/R injury in diabetic rats validation diabetic nephropathy 0.900 0.00 streptozotocin-induced diabeti proposed N/A
HFD-induced cognitive dysfunction and neuroinflammation in mice validation diet-induced cognitive dysfunc 0.900 0.00 adult Swiss male mice proposed N/A
TLR expression analysis in Parkinson's disease patients clinical Parkinson's disease 0.850 0.00 human patients proposed N/A
Resveratrol effects on HK-2 cells under hypoxia/reoxygenation exploratory diabetic nephropathy 0.850 0.00 HK-2 cells cultured in high gl proposed N/A
TLR4 Activation Assay with NETs and Anti-CarP Antibodies exploratory rheumatoid arthritis 0.850 0.00 HEK293 TLR4 reporter cells proposed N/A
α7nAChR agonist treatment rescues HFD-induced memory deficits validation diet-induced cognitive dysfunc 0.850 0.00 HFD-fed adult Swiss male mice proposed N/A
TLR expression in α-synuclein overexpressing mice validation Parkinson's disease 0.800 0.00 mice overexpressing human α-sy proposed N/A
α7nAChR knockout mice show enhanced HFD sensitivity validation diet-induced cognitive dysfunc 0.800 0.00 Chrna7 knockout mice proposed N/A

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214] Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia J Inflamm Res 2022 1
Astrocytic α7-nicotinic acetylcholine receptors mediate pain information process [PMID:41453579] Teng T, Yang S, Li J, Wang H, Wu F, He Y Neurobiology of disease 2026 0
Signal-Level Determinants of Cognitive Decline With PPIs versus H2RAs: Transport [PMID:41663888] Saihati HAA, Ahmed BY, Mosaad RM, El-Gar Molecular nutrition & food res 2026 0
Podocyte TLR4 deletion alleviates diabetic kidney disease through prohibiting PK [PMID:40659086] Li Z, Tan D, Lin J, Zhang T, Liu B et al J Adv Res 2026 0
Celastrol treatment attenuates the inflammatory response in Alzheimer's disease [PMID:40762111] Cao F, Zhang P, Zheng Z, Wang P, Wang Y Neurol Res 2026 0
CircCramp1l targets the miR-532-3p/HMGB1/Drp1 axis to regulate allergic rhinitis [PMID:41519399] Zhang Y, Wang J, Song Y, Chai J, Li L et Biochem Pharmacol 2026 0
Neuronal TLR4 upregulation activates the cGAS-STING pathway to induce ferroptosi [PMID:41702081] Qin H, Yang L, Du J, Xu X, Chen Z et al. Int Immunopharmacol 2026 0
2'-Fucosyllactose Alleviates Metabolic Hypertension in Mice via Gut Microbiota M [PMID:41926238] Chen J, Liang S, Liu D, Yang S, Yan Q et J Agric Food Chem 2026 0
Leveraging intraperitoneal delivery of toll-like receptor agonists to treat peri [PMID:41926324] Yan H, Chia D, Ernst S, Demuytere J, Cos Expert Opin Drug Deliv 2026 0
Small-molecule PCSK9 inhibition enhances BBB amyloid-β clearance and suppresses [PMID:41927877] Miao J, Wang J, Zhou W, Guo J Sci Rep 2026 0
Nicotine Suppresses Human Memory Th Cell Subsets With Preferential Effects on Ce [PMID:41928597] Gholizadeh F, Hajiaghayi M, Rahbari N, C Eur J Immunol 2026 0
Anti-carbamylated protein antibodies stabilize carbamylated Histone H3 to promot [PMID:41930627] Nakabo S, Hanata N, Patino-Martinez E, H Arthritis Rheumatol 2026 0
In silico design of a novel multi-epitope mRNA vaccine candidate for BtHKU5-CoV- [PMID:41931545] Zheng N, Xu Y PLoS Negl Trop Dis 2026 0
Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF. [PMID:41931597] Ma B, Lyu W, Rizk J, Han X, Kjær M et al Sci Immunol 2026 0
Interweaving microglial senescence and gut microbiome dynamics in Alzheimer's di [PMID:41747877] Waghmare A, Rahangdale S, Khare K, Taksa Molecular and cellular neurosc 2026 0
Alpha 7 nicotinic acetylcholine receptor contributes to long-term cognitive reco [PMID:41270982] Nguyen DT, Mendoza K, Hall C, Tan C, Cha Experimental neurology 2026 0
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders [PMID:41699128] ["Bolsewig K", "Bellomo G", "Hok-A-Hin Y Nature medicine 2026 0
Nanopiezoelectric 3D-Bioprinted Neural Organoid Models Epileptic Neuron-Microgli [PMID:41877549] Chu J, Hu K, Lee WF, Xu SJ, Sun Z, Xu Y, Nano letters 2026 0
Putative α7-selective ligands interact with α9-containing nicotinic acetylcholin [PMID:41890755] Mobasher M, Hone AJ, Pilzecker M, Bozic Frontiers in immunology 2026 0
The Neuroameliorative Effects of Enzymatically Modified Isoquercitrin and Sodium [PMID:41880086] Hassouna I, Hassanein OH, El-Elaimy IA, Neurochemical research 2026 0

Debates (20)

Multi-agent debates referencing this entity

Debate: SCFA Deficiency Drives Microglial Hyperactivation via GPR43/NF-κB Dysreg

closed · Rounds: 4 · Score: 0.13 · 2026-04-27

Hypothesis debate: Microbial Inflammasome Priming Prevention

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegen

closed · Rounds: 4 · Score: 0.76 · 2026-04-26

Formal debate: TLR4 priming is the actionable driver in: How does gut microbiome

closed · Rounds: 3 · Score: 0.75 · 2026-04-26

Formal debate: plasma LPS-binding protein separates causal from compensatory sta

closed · Rounds: 3 · Score: 0.75 · 2026-04-26

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegen

closed · Rounds: 4 · Score: 0.78 · 2026-04-26

Hypothesis debate: SCFA Deficiency Disrupts Microglial Homeostasis and Promotes

closed · Rounds: 4 · Score: 0.60 · 2026-04-26

Hypothesis debate: Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propag

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Enteric Nervous System Dysfunction as Self-Reinforcing Pathol

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Related Research

Hypotheses and analyses mentioning gut in their description or question text

Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Com

Score: 0.669 · neurodegeneration · 2026-04-02

## Mechanistic Overview Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Communication start

Physiological SCFAs may reduce alpha-synuclein burden primarily through a gut-fi

Score: 0.650 · neurodegeneration · 2026-04-24

Low-micromolar systemic SCFA exposure is unlikely to directly drive substantia nigra alpha-synuclein clearance, but colo

Gut-Brain Axis M-Cell Modulation

Score: 0.629 · unknown disease · 2026-04-04

## Mechanistic Overview Gut-Brain Axis M-Cell Modulation starts from the claim that modulating GP2, SPIB within the dise

H7: Enteric Nervous System Alpha-Synuclein Propagation Blocker via Gut Barrier R

Score: 0.620 · neurodegeneration · 2026-04-15

## Mechanistic Overview H7: Enteric Nervous System Alpha-Synuclein Propagation Blocker via Gut Barrier Restoration start

Correcting Gut Microbial Dopamine Imbalance to Support Systemic Dopaminergic Fun

Score: 0.606 · neurodegeneration · 2026-04-02

## Mechanistic Overview Correcting Gut Microbial Dopamine Imbalance to Support Systemic Dopaminergic Function starts fro

Gut Bacterial Metabolite-AhR Dysregulation Converts SCFA-Deficiency into IDO1-Dr

Score: 0.580 · neurodegeneration · 2026-04-26

Aryl hydrocarbon receptor (AhR), expressed in microglia, astrocytes, and neurons, normally ligates tryptophan catabolite

Gut-Brain Axis Microbiome Modulation

Score: 0.557 · Alzheimer's disease · 2026-04-04

# Gut-Brain Axis Microbiome Modulation: Preventing Neurodegeneration Through GPR43/GPR109A Signaling ## Scientific Ba

TLR2 Recognition of Gut-Derived Fungal and Bacterial D-Alanylated Lipoteichoic A

Score: 0.550 · neurodegeneration · 2026-04-26

Dysbiosis permits overgrowth of SIBO species and opportunistic fungi (Candida albicans, Malassezia) whose cell wall comp

Cross-Seeding: Gut Microbiome-Derived Bacterial Curli and Fungal Amyloid Synergi

Score: 0.540 · neurodegeneration · 2026-04-26

Commensal bacteria (E. coli, Salmonella) produce curli amyloid fibers encoded by the csg operon, while Candida and Sacch

Gut Barrier Permeability-α-Synuclein Axis Modulation

Score: 0.533 · neurodegeneration · 2026-04-02

Dysbiotic bacteria compromise intestinal barrier integrity through zonulin pathway activation, allowing bacterial antige

Gut-derived butyrate reprograms microglia for amyloid clearance via HDAC2 inhibi

Score: 0.525 · Alzheimer's disease · 2026-04-26

Specific butyrate-producing gut bacteria (e.g., Faecalibacterium, Roseburia) generate systemic butyrate that crosses the

Gut dysbiosis-driven monocyte reprogramming toward NETotic phenotype accelerates

Score: 0.380 · Alzheimer's disease · 2026-04-27

Intestinal barrier dysfunction and LPS translocation primes CCR2+ circulating monocytes and neutrophils toward a NETosis

Gut butyrate deficiency impairs microglial amyloid clearance via HDAC2-mediated

Score: 0.380 · Alzheimer's disease · 2026-04-27

Gut dysbiosis in Alzheimer's disease reduces butyrate-producing bacteria (Faecalibacterium prausnitzii, Roseburia intest

plasma LPS-binding protein separates causal from compensatory states in: How doe

Score: 0.346 · neurodegeneration · 2026-04-26

A longitudinal biomarker panel centered on plasma LPS-binding protein can distinguish harmful mechanisms from protective

TLR4 priming is the actionable driver in: How does gut microbiome dysbiosis cont

Score: 0.343 · neurodegeneration · 2026-04-26

The gap can be tested by treating TLR4 priming as an upstream driver rather than a passive correlate. If true, perturbin